254 related articles for article (PubMed ID: 34042518)
1.
Yang Q; Qi M; Chen Y; Tian S; Liao F; Dong W
DNA Cell Biol; 2021 Jul; 40(7):921-935. PubMed ID: 34042518
[TBL] [Abstract][Full Text] [Related]
2. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
Liu X; Liu X; Li J; Ren F
Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
[TBL] [Abstract][Full Text] [Related]
3. Identification of Hub genes with prognostic values in colorectal cancer by integrated bioinformatics analysis.
Li S; Li T; Shi YQ; Xu BJ; Deng YY; Sun XG
Cancer Biomark; 2024; 40(1):27-45. PubMed ID: 38393891
[TBL] [Abstract][Full Text] [Related]
4. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
Li J; Liu X; Cui Z; Han G
Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
[TBL] [Abstract][Full Text] [Related]
6. Integrative Gene Expression Profiling Analysis to Investigate Potential Prognostic Biomarkers for Colorectal Cancer.
Liu X; Bing Z; Wu J; Zhang J; Zhou W; Ni M; Meng Z; Liu S; Tian J; Zhang X; Li Y; Jia S; Guo S
Med Sci Monit; 2020 Jan; 26():e918906. PubMed ID: 31893510
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysis.
Chen J; Wang Z; Shen X; Cui X; Guo Y
Mol Genet Genomic Med; 2019 Jul; 7(7):e00713. PubMed ID: 31087508
[TBL] [Abstract][Full Text] [Related]
8. Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis.
Gong K; Zhou H; Liu H; Xie T; Luo Y; Guo H; Chen J; Tan Z; Yang Y; Xie L
Technol Cancer Res Treat; 2021; 20():15330338211060202. PubMed ID: 34825846
[No Abstract] [Full Text] [Related]
9. Identification of hub genes in colorectal cancer based on weighted gene co-expression network analysis and clinical data from The Cancer Genome Atlas.
Zhang Y; Luo J; Liu Z; Liu X; Ma Y; Zhang B; Chen Y; Li X; Feng Z; Yang N; Feng D; Wang L; Song X
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34308980
[TBL] [Abstract][Full Text] [Related]
10. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
11. Identification of potential therapeutic targets associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Sharma A; Yadav D; Rao P; Sinha S; Goswami D; Rawal RM; Shrivastava N
Comput Biol Med; 2022 Jul; 146():105688. PubMed ID: 35680454
[TBL] [Abstract][Full Text] [Related]
12. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
Yu C; Chen F; Jiang J; Zhang H; Zhou M
Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
[TBL] [Abstract][Full Text] [Related]
13. Identification of candidate aberrantly methylated and differentially expressed genes in Esophageal squamous cell carcinoma.
Han BA; Yang XP; Hosseini DK; Zhang P; Zhang Y; Yu JT; Chen S; Zhang F; Zhou T; Sun HY
Sci Rep; 2020 Jun; 10(1):9735. PubMed ID: 32546690
[TBL] [Abstract][Full Text] [Related]
14. Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis.
Qi C; Chen Y; Zhou Y; Huang X; Li G; Zeng J; Ruan Z; Xie X; Zhang J
Oncol Rep; 2018 May; 39(5):2297-2305. PubMed ID: 29517105
[TBL] [Abstract][Full Text] [Related]
15. Identification of potential hub genes via bioinformatics analysis combined with experimental verification in colorectal cancer.
Zhou H; Yang Z; Yue J; Chen Y; Chen T; Mu T; Liu H; Bi X
Mol Carcinog; 2020 Apr; 59(4):425-438. PubMed ID: 32064687
[TBL] [Abstract][Full Text] [Related]
16. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
Yue Y; Zhang Q; Sun Z
Front Immunol; 2021; 12():758040. PubMed ID: 35140706
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics Analysis Identified Key Molecular Changes in Bladder Cancer Development and Recurrence.
Chen Q; Hu J; Deng J; Fu B; Guo J
Biomed Res Int; 2019; 2019():3917982. PubMed ID: 31828101
[No Abstract] [Full Text] [Related]
18. Identification of Genes Related to Clinicopathological Characteristics and Prognosis of Patients with Colorectal Cancer.
Gao X; Yang J
DNA Cell Biol; 2020 Apr; 39(4):690-699. PubMed ID: 32027181
[TBL] [Abstract][Full Text] [Related]
19. ASPM promotes glioblastoma growth by regulating G1 restriction point progression and Wnt-β-catenin signaling.
Chen X; Huang L; Yang Y; Chen S; Sun J; Ma C; Xie J; Song Y; Yang J
Aging (Albany NY); 2020 Jan; 12(1):224-241. PubMed ID: 31905171
[TBL] [Abstract][Full Text] [Related]
20. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]